The Pathology Network
PrivateLast Round
Accelerator
Jun 14, 2024
Total Funding Raised
$750,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
The Pathology Network operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was an Accelerator round in June 2024.
The Pathology Network is a healthtech company that operates a digital diagnostic management platform, Spes360, to connect hospitals and doctors in Africa with a global network of specialized laboratories and pathologists.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, InsurTech
Business Model
B2B
Customer Profile
Marketplace Commission, Subscription SaaS, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
The Pathology Network Comparables
Compare The Pathology Network with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healthshare Health Solutions | 64% | |
| Lancet Laboratories | 62% | |
| Ampath | 62% |
For institutional investors. Book with your work email.
The Pathology Network Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 14, 2024 | ||||
| Seed | Jan 1, 2023 | ||||
| Grant | Sep 27, 2022 | ||||
| Seed | Jun 2, 2021 | ||||
| Pre Seed | May 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
The Pathology Network Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Hub Africa | Accelerator |
| Villgro Africa | Seed, Pre Seed |
| Jaza Rift Ventures | Seed |
| Kua Ventures | Seed |
| Investing in Innovation (i3) Africa | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 645% MoM, from 185 to 1.4K.
- Jul 30, 2025
Attended the 2nd National Cancer Summit organized by the National Cancer Institute of Kenya.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 25, 2026
On Sep 25th '26, The Pathology Network Ltd and Cerba Lancet Kenya Limited announce a strategic partnership in Kenya to expand access to routine and specialised diagnostic testing across East Africa.
For institutional investors. Book with your work email.
The Pathology Network Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about The Pathology Network's valuation, stock price, and market status.
Is The Pathology Network a public or private company?
The Pathology Network is a private company.
What is the current stock price of The Pathology Network?
The Pathology Network is a private company, so its shares have no public market price. Caplight tracks The Pathology Network's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is The Pathology Network worth (valuation)?
Valuation information for The Pathology Network is not publicly available.
Can I buy The Pathology Network stock?
The Pathology Network shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was The Pathology Network's last funding round?
The Pathology Network's most recent funding round was Accelerator on June 14, 2024.
Who are the main investors in The Pathology Network?
Key investors in The Pathology Network include Villgro Africa.
Will The Pathology Network IPO soon?
No public IPO plans have been announced for The Pathology Network.
How can I track The Pathology Network secondary market activity?
Caplight tracks bids, offers, and trades in The Pathology Network's shares on secondary markets.